title: Growth stimulation of a human colorectal carcinoma cell line by interleukin-1 and -6 and antagonistic effects of transforming growth factor beta 1.
abstract: We analysed the effect of interleukin-1 (IL-1), IL-6 and transforming growth factor beta 1 (TGF beta 1) on the growth of a panel of eight colorectal carcinoma cell lines. IL-1 stimulated growth of two lines (LS411N and LS1034) up to 20-fold and IL-6 enhanced proliferation of LS1034 more than 5-fold. Both cytokines also augmented colony-formation of LS1034 in methylcellulose. Under both growth conditions IL-1 was the most potent stimulator. However, the addition of IL-6 to IL-1 synergistically enhanced proliferation of LS1034 in monolayer culture and additively augmented the number of colonies formed in methylcellulose. Furthermore, TGF beta 1 strongly reduced the growth rate of LS1034. Low amounts of TGF beta 1 markedly inhibited the response of LS1034 to IL-1 and totally abrogated proliferation induced by IL-6. We conclude that different cytokines can provide distinct signals for the regulation of growth of colorectal carcinoma cells.
authors.affiliation: Swiss Institute for Experimental Cancer Research, Department of Cellular Biology, Epalinges.
authors.forename: H
authors.initials: H
authors.lastname: Lahm
authors.forename: D
authors.initials: D
authors.lastname: Petral-Malec
authors.forename: A
authors.initials: A
authors.lastname: Yilmaz-Ceyhan
authors.forename: J R
authors.initials: JR
authors.lastname: Fischer
authors.forename: M
authors.initials: M
authors.lastname: Lorenzoni
authors.forename: J C
authors.initials: JC
authors.lastname: Givel
authors.forename: N
authors.initials: N
authors.lastname: Odartchenko
mesh_terms: D002455:Cell Division / Q000187:drug effects; D015179:Colorectal Neoplasms / Q000473:pathology*; D004357:Drug Synergism; D006801:Humans; D007375:Interleukin-1 / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D007376:Interleukin-2 / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D008938:Mitosis / Q000187:drug effects; D011994:Recombinant Proteins / Q000494:pharmacology; D016212:Transforming Growth Factor beta / Q000494:pharmacology*; D014407:Tumor Cells, Cultured / Q000187:drug effects; D014410:Tumor Stem Cell Assay
chemical_list: D007375:Interleukin-1; D007376:Interleukin-2; D011994:Recombinant Proteins; D016212:Transforming Growth Factor beta